75 results on '"Anti il 5"'
Search Results
2. Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain
3. Exacerbations of Severe Asthma While on Anti–IL-5 Biologics
4. Subcutaneous Mepolizumab Injection: An Adjunctive Treatment for Recalcitrant Allergic Fungal Rhinosinusitis Patients With Asthma
5. Anti-IL-5 monoclonal antibodies for the treatment of asthma: an update
6. Anti-IL-5 Biologicals Targeting Severe Late Onset Eosinophilic Asthma
7. Late Breaking Abstract - Two-year cumulative oral corticosteroid exposure in severe eosinophilic asthma before and after anti-IL-5 therapy
8. Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma
9. Characteristics of super-responders to anti IL-5 biologics in a nationwide Danish severe asthma cohort
10. Worldwide Characterization of Severe Asthma Patients Eligible for Both Anti-IL5 and Anti-IgE: Data from the International Severe Asthma Registry (ISAR)
11. Efficacy and safety of mepolizumab in a real-world cohort of patients with severe eosinophilic asthma
12. The Role of Eosinophils in Allergic Inflammation Indicated by the Effect of Anti-IL-5 Therapy to Asthma
13. Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting
14. Asthma
15. Complications of switching from anti-IL-5 or anti-IL-5R to dupilumab in corticosteroid-dependent severe asthma
16. Cardiovascular adverse effects of anti-IL-5/IL-5Rα therapies: A real-world study
17. Serum Amphiregulin expression in severe asthma patients treated with anti-IL-5 therapy
18. Mepolizumab in childhood onset steroid dependent eosinophilic granulomatosis with polyangiitis
19. Predictors of response to anti-IL-5 biologics
20. Real-World Effectiveness of Anti IL-5/IL-5R Therapies in Severe Asthma with Fungal Sensitisation
21. Immuno-Histological Analysis of Sinusitis Tissue from the Cases Who Were Not Fully Improved After Anti-IL-5 Therapy
22. P88 Real-world effectiveness of anti-IL-5/5R therapies in severe atopic eosinophilic asthmatics eligible for anti-IgE therapy
23. M173 SUCCESSFUL MANAGEMENT OF EOSINOPHILIC MYOCARDITIS IN A PATIENT WITH IDIOPATHIC HYPEREOSINOPHILIC SYNDROME WITH ANTI-IL-5 THERAPY
24. USE OF ANTI-IL-5 (MEPOLIZUMAB) AS RESCUE THERAPY FOR STATUS ASTHMATICUS REQUIRING VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION
25. ANTI-IL-5-RECEPTOR TREATMENT IN SEVERE ASTHMA: REAL LIFE DATA
26. Mepolizumab use
27. Impact of age on the efficacy of anti-IL-5 monoclonal antibodies in severe asthmatics
28. Effects of anti-IL-5 receptor alpha in an ex vivo 3D model of COPD
29. The effect of anti-IL-5 therapy on sputum cells and cytokines in asthmatics
30. Disparate Eosinophilic Phenotypes with Age: Impact on Eligibility for Anti-IL-5 Therapies in Severe Asthma
31. Assessment of Response to Anti-IL-5 Monoclonal Antibodies in a Tertiary Care Centre: A Real-Life Study
32. High Failure Rate of Anti-IL-5 Therapies in Prednisone-Dependent Asthma Is Associated with Airway Autoimmune Responses
33. Controversies in Allergy: Should Severe Asthma with Eosinophilic Phenotype Always Be Treated with Anti-IL-5 Therapies
34. Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria
35. Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy
36. S2755 Clinical Remission and Histoendoscopic Improvement With Mepolizumab Anti-IL-5 in a Child With Eosinophilic Crohn's Colitis vs Idiopathic Eosinophilic Colitis: A Rose By Any Other Name?
37. The effect of mepolizumab, an anti-IL-5 monoclonal antibody, on eosinophilic otitis media associated with severe asthma
38. Correction to: Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions
39. Exhaled Nitric Oxide in Severe Asthmatics Receiving Anti-IL-5 Therapy
40. Effects of Anti-IL-5 on Virus-induced Exacerbation in Asthma. Light and Shadow
41. Patients eligible for anti-IL-5/anti-IL-5Ra treatment in a cohort of adult-onset asthma
42. What are the benefits and harms of anti-IL-5 therapies for adults with asthma?
43. Anti-IL-5 for Severe Asthma
44. Biologic Therapies for Immunoglobulin E-mediated Food Allergy and Eosinophilic Esophagitis
45. Biologic and New Therapies in Asthma
46. Human(ized) monoclonal antibodies in atopic patients - state of the art
47. Is Anti-IL 5 Therapy Effective in Eosinophilic Granulomatosis With Polyangiitis?
48. Humanized Anti-IL-5 Antibody Therapy
49. ANTI-IL-5 AGENTS IN THE TREATMENT OF EOSINOPHILIC COPD: A SYSTEMATIC REVIEW AND META-ANALYSIS
50. Use of biologicals as immunotherapy in asthma and related diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.